Infectious Diseases

Aurobindo Pharma Q2 net profit up 33.53% to Rs. 606 cr Aurobindo Pharma reported 33.53 per cent rise in consolidated net profit to Rs 605.64 crore for the quarter ending September mainly on account of robust formulation sales. The company had posted a net profit after tax, minority interest and share of profit of joint ventures of Rs 453.55 crore for the same period a year ago. Consolidated total income from operations also rose to Rs 3,775.45 crore for the quarter under consideration as against Rs 3,365.11 crore for the corresponding period of the previous fiscal. The Leukemia & Lymphoma Society (LLS) Selects INC Research for AML Master Trial The Beat AML Master ...